| http://www.w3.org/ns/prov#value | - on to mesothelioma display elevated levels of HMGB1, including melanoma, prostate, pancreatic, breast and gastrointestinal cancers (42), therapies that seek to block HMGB1 signaling would likely prove effective in other cancer types in addition to mesothelioma.Treatment with an IL-1 receptor antagonist can protect mice from developing fibrosis upon exposure to bleomycin or silica (58); and in a mu
|
